FDA Investigator Charles J Chacko

Charles J Chacko has conducted inspections on 95 sites in 7 countries as of 06 Nov 2015. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
95
Last Inspection Date:
06 Nov 2015
Investigator Role:
FDA Investigation Participant
Redica ID:
100000804
Countries of Inspections:
United States of America, Ireland, France, China, United Kingdom of Great Britain and Northern Ireland, Germany, Japan
FDA Investigators that have inspected at least one site in common with Charles J Chacko:
Addam S Reynolds, Alberto A Viciedo, Allen Lou, Althea A Williams, Amy A Johnson, Amy L Singer, Amy M Codella, Amy M Cramer, Annette A Ragosta, Anthony M Criscuolo, Jr, Barbara J Maulfair, Barbara Jwilimczyk Macri, Byungja E Marciante, Cary Greene, Cassandra Gasby, Charles L Larson, Cheryl A Grandinetti, Chiang Syin, PhD, Christina N Maurino, Craig W Swanson, Daniel J Grabicki, David H Smith, Deborah B Nixon, Demitria J Xiradakis, Denise M Visco, Investigator, Dolores Harper, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Edward O'shaughnessy, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Frank A Boardwick, Frank J Marciniak, Frederick F Razzaghi, George Pyramides, Gianine E Tompkins, Gobiga Vanniyasingam, Gregson A Joseph, Guerlain Ulysse, Haitao Li, Helen Verdel, Jacqueline S Warner, James D Planchon, Janet A Rajan, Jason M Sluzynski, Jean M Kelahan, Jeffrey J Ebersole, Jennifer L Custodio, Joan A Loreng, Jocelyn C Turner, Jogy George, Jonathan Ho, Jose M Cayuela, Jose V Obando, Joshua J Silvestri, Joy Rkozlowski Klena, Juanita P Versace, Justine Tomasso, K Gonzlez, Karen E D'orazio, Kassa Ayalew, MD, Kazi Rafiquzzaman, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kerry A Kurdilla, Kinh Q Mac, Kris K Moore, Krishnaiah Yellela, Kristen E Rescigno, Kristy A Zielny, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, Li Li, Liatte Kreuger, PharmD, Lisa Harlan, Lisa Mathew, Lori S Lawless, LT Colin E Tack, BSE, Marcelo O Mangalindan, Jr, Margaret M Sands, Maria Manzoni, PhD, Marjorie D Schultz, Maryam Tabatabaie, Matthew A Spataro, Matthew W Kyle, Mayar M Mussa, Melanie W Pishnery, Melba Trivera Clavell, Melissa A Freeman, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Michael R Klapal, Michael Serrano, Miguel Gmanzano Maldonado, Msdap Gonzlezk, Naakesh N Gomanie, Nancy F Scheraga, Nicholas A Violand, Niketa Patel, Nina Yang, Paul L Bellamy, Peter R Lenahan, Philip F Istafanos, DMV, MS, Regina T Brown, Remache, Richard D Manney, Robert G Ruff, Robert Jennings, Rodney T Allnutt, Ronald Ifraimov, Russell J Glapion, Sandra Kershaw, Sarah Forney, Schultz, Shahla Parvizi, Sherri J Liu, Simone E Pitts, Sinai I Davis, Stephanie T Durso, Stephen J Mottola, Stephenie M Ortiz, Steven M Weinman, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Tonia F Bernard, Toyin B Oladimeji, Tressa T Lewis, Tyanna N Hadley, Valerie C Reed, Wayne J Meyer, William R Chang, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhugong Liu

Charles J Chacko's Documents

Publish Date Document Type Title
September, 2009 EIR Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - EIR, 2009-09-09
November, 2013 FDA 483 BioArray Solutions, Ltd. - Form 483, 2013-11-15
September, 2010 EIR Queseria Chipilo, Inc. - EIR, 2010-09-23
June, 2012 FDA 483 Cargille-Sacher Laboratories Inc. - Form 483, 2012-06-08
July, 2012 FDA 483 Bloomex International, Inc. - Form 483, 2012-07-02
November, 2012 FDA 483 Bipore Medical Devices, Inc. - Form 483, 2012-11-19
September, 2010 EIR Novartis Pharmaceuticals Corporation - EIR, 2010-09-03
November, 2014 FDA 483 Sonar Products, Inc. - Form 483, 2014-11-13
May, 2012 EIR DERMARITE INDUSTRIES, LLC - EIR, 2012-05-10
May, 2014 FDA 483 NPS Pharmaceuticals, Inc. - Form 483, 2014-05-13
August, 2011 FDA 483 Englewood Lab, Inc. - Form 483, 2011-08-25
December, 2011 FDA 483 Collagen Matrix, Inc. - Form 483, 2011-12-05
June, 2015 FDA 483 Genesis BPS, LLC. - Form 483, 2015-06-10
February, 2013 EIR Genesis BPS, LLC. - EIR, 2013-02-11
February, 2014 FDA 483 Organics Corporation of America DBA Ambix Laboratories - Form 483, 2014-02-24
October, 2014 FDA 483 Response Nephros, Inc. - Form 483R, 2014-11-13
March, 2011 FDA 483 Pentax of America Inc - Form 483, 2011-03-17
January, 2014 FDA 483 Fujifilm Medical Systems U.S.A., Inc. - Form 483, 2014-01-16
September, 2011 FDA 483 Surgical Concept Designs - Form 483, 2011-09-23
May, 2013 FDA 483 Vitaire Corp. - Form 483, 2013-05-09
October, 2013 FDA 483 Maquet Cardiovascular, LLC - Form 483, 2013-10-16
August, 2014 FDA 483 Ethicon, Inc. - Form 483, 2014-08-07
January, 2012 FDA 483 Case Medical, Inc. - Form 483, 2012-01-23
November, 2010 EIR Queseria Chipilo, Inc. - EIR, 2010-11-08
October, 2014 FDA 483 Nephros, Inc. - Form 483, 2014-10-24
August, 2010 EIR Queseria Chipilo, Inc. - EIR, 2010-08-18
February, 2013 FDA 483 Genesis BPS, LLC. - Form 483, 2013-02-11
October, 2014 EIR Nephros, Inc. - EIR, 2014-10-24
May, 2012 FDA 483 DERMARITE INDUSTRIES, LLC - Form 483, 2012-08-07
January, 2013 FDA 483 ADM Tronics Unlimited, Inc. - Form 483, 2013-01-18
October, 2013 FDA 483 Datascope Corp. - Form 483, 2013-10-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more